Filippi and collaborators provided the first evidence that Breast Cancer (BC) cells displayed an increased expression of CSA protein, and that its ablation by AntiSense Oligonucleotides (ASOs) drastically impaired the tumorigenicity of BC cells by hampering their survival and proliferative capabilities without affecting normal breast cells. Here, ERCC8 is linked to breast cancer.